ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

DARBEPOETINUM ALFA

Active substance (INN) · ATC B03XA02 · 16 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
B011N	DARBEPOETINUM ALFA	In force	medicine of the protocol	C1-G25 si C2 -P10	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
ARANESP 100µg/0,5ml	SOL. INJ. IN SERINGA PREUMPLUTA	100µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 100µg/0,5ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	100µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 10µg/0,4ml	SOL. INJ. IN SERINGA PREUMPLUTA	10µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 10µg/0,4ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	10µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 130µg/0,65ml	SOL. INJ. IN SERINGA PREUMPLUTA	130µg/0,65ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 130µg/0,65ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	130µg/0,65ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 15µg/0,375ml	SOL. INJ. IN SERINGA PREUMPLUTA	15µg/0,375ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 15µg/0,375ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	15µg/0,375ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 15µg/ml	SOL. INJ. IN FLACON	15µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 20µg/0,5ml	SOL. INJ. IN SERINGA PREUMPLUTA	20µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 20µg/0,5ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	20µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 25µg/ml	SOL. INJ. IN FLACON	25µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 300µg/0,6ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	300µg/0,6ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 30µg/0,3ml	SOL. INJ. IN SERINGA PREUMPLUTA	30µg/0,3ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 30µg/0,3ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	30µg/0,3ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 40µg/0,4ml	SOL. INJ. IN SERINGA PREUMPLUTA	40µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 40µg/0,4ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	40µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 40µg/ml	SOL. INJ. IN FLACON	40µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 500µg/ml	SOL. INJ. IN SERINGA PREUMPLUTA	500µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 500µg/ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	500µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 50µg/0,5ml	SOL. INJ. IN SERINGA PREUMPLUTA	50µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 50µg/0,5ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	50µg/0,5ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 60µg/0,3ml	SOL. INJ. IN SERINGA PREUMPLUTA	60µg/0,3ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 60µg/0,3ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	60µg/0,3ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 60µg/ml	SOL. INJ. IN FLACON	60µg/ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 80µg/0,4ml	SOL. INJ. IN SERINGA PREUMPLUTA	80µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R
ARANESP 80µg/0,4ml	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	80µg/0,4ml	AMGEN EUROPE BV - OLANDA	B03XA02	P-RF/R

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.